The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial

BACKGROUND: Several clinical trials and recent meta-analyses have demonstrated that administration of recombinant human granulocyte-colony stimulating factor (G-CSF) is safe and, only in patients with large acute myocardial infarction (AMI), is associated with an improvement in left ventricular ejec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Leone, Antonio Maria, D’Amario, Domenico, Teofili, Luciana, Basile, Eloisa, Cannata, Francesco, Graziani, Francesca, Marzilli, Mario, Russo, Antonio Matteo, Tarantini, Giuseppe, Ceconi, Claudio, Leone, Giuseppe, Trani, Carlo, Rebuzzi, Antonio Giuseppe, Crea, Filippo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4759781/
https://ncbi.nlm.nih.gov/pubmed/26891753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1172-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados